These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 1932287

  • 1. Ultrapure plasma factor VIII produced by anti-F VIII c immunoaffinity chromatography and solvent/detergent viral inactivation. Characterization of the Method M process and Hemofil M antihemophilic factor (human).
    Griffith M.
    Ann Hematol; 1991 Sep; 63(3):131-7. PubMed ID: 1932287
    [No Abstract] [Full Text] [Related]

  • 2. Inactivation and removal of human immunodeficiency virus in monoclonal purified antihemophilic factor (human) (Hemofil M).
    Piszkiewicz D, Sun CS, Tondreau SC.
    Thromb Res; 1989 Sep 01; 55(5):627-34. PubMed ID: 2510362
    [Abstract] [Full Text] [Related]

  • 3. Antihemophilic factor isolated with monoclonal antibodies.
    Gomperts ED.
    Ann Hematol; 1991 Sep 01; 63(3):142-4. PubMed ID: 1932289
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Viral safety and inhibitor development associated with monoclonal antibody-purified F VIII C.
    Lusher JM.
    Ann Hematol; 1991 Sep 01; 63(3):138-41. PubMed ID: 1932288
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Products for the treatment of hemophilia A and B prepared by ion exchange chromatography.
    Sultan Y, Boyeldieu D, Stieltjes N.
    Nouv Rev Fr Hematol (1978); 1994 Sep 01; 36 Suppl 1():S59-60. PubMed ID: 8177717
    [Abstract] [Full Text] [Related]

  • 11. Recombinant antihemophilic factor.
    Med Lett Drugs Ther; 1993 Jun 11; 35(898):51-2. PubMed ID: 8497206
    [No Abstract] [Full Text] [Related]

  • 12. Characterization of highly purified factor VIII products.
    Beeser H.
    Ann Hematol; 1991 Sep 11; 63(3):126-30. PubMed ID: 1657208
    [No Abstract] [Full Text] [Related]

  • 13. [Anti-hemophilia drugs: from cryoprecipitate to factor VIII concentrates of high purity].
    Gutsalo AE, Varetskaia TV, Kozulina EP, Papaian LP.
    Ukr Biokhim Zh (1978); 1995 Sep 11; 67(1):3-13. PubMed ID: 8588250
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Porcine factor VIII: past, present and future.
    Hay CR.
    Haematologica; 2000 Oct 11; 85(10 Suppl):21-4; discussion 24-5. PubMed ID: 11187865
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Therapy of hemophilia A with a cryoprecipitated antihemophilic factor].
    Ollendorff P.
    Ugeskr Laeger; 1969 May 15; 131(20):877-81. PubMed ID: 5795169
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.